The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733).

@article{OReilly2015TheVO,
  title={The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733).},
  author={Elma Anna OʼReilly and Ruth S. Prichard and Dhafir Al Azawi and Nitin Aucharaz and Gabrielle Kelly and Denis Evoy and James Geraghty and Jane R Rothwell and Ann OʼDoherty and Cecily Quinn and Stephen J. Skehan and Enda W M McDermott},
  journal={Annals of surgery},
  year={2015},
  volume={262 2},
  pages={243-8}
}
BACKGROUND Sentinel lymph node biopsy (SLNB) has become the gold standard for axillary staging. Debate remains as to the optimal method of SLN detection. OBJECTIVES Determine whether patients undergoing an SLNB required the addition of isosulfan blue dye to radioisotope when an SLN was identified on a preoperative lymphoscintigram. METHODS A prospective randomized controlled trial comparing the combination of radioisotope and blue dye versus radioisotope alone was performed between March… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 16 times over the past 90 days. VIEW TWEETS